Colony-Stimulating Factors

After chemotherapy crushes the white count, filgrastim is the drug that rebuilds it — but giving it at the wrong time can destroy the very cells you're trying to save.

Colony-stimulating factors (CSFs) like filgrastim (Neupogen) and pegfilgrastim (Neulasta) stimulate the bone marrow to produce neutrophils. They work by binding to receptors on neutrophil precursor cells, accelerating their maturation and release into the bloodstream. The primary indication is chemotherapy-induced neutropenia — specifically to shorten the duration of severe neutropenia (ANC below 500 cells/mm³) and reduce infection risk. Filgrastim is given as a daily subcutaneous injection starting 24 hours after the last chemotherapy dose — never during or within 24 hours of chemo administration, because rapidly dividing marrow cells stimulated by filgrastim become vulnerable to cytotoxic agents. Pegfilgrastim is the long-acting form given once per cycle, also no sooner than 24 hours post-chemo. Treatment continues until the ANC recovers, typically above 10,000 cells/mm³ per provider protocol. Monitor CBC with differential frequently — the goal is a rising ANC. The most common adverse effect is bone pain, often in the sternum, pelvis, and long bones, caused by marrow expansion as neutrophil production ramps up. Mild-to-moderate analgesics (acetaminophen, NSAIDs) usually manage this. Rare but serious risks include splenic rupture — teach the client to report sudden left upper quadrant or shoulder pain immediately.

Key Distinctions

Don't confuse filgrastim (stimulates white cells/neutrophils) with epoetin alfa (stimulates red cells) or oprelvekin (stimulates platelets) — each CSF targets a different cell line. Students commonly think filgrastim can be given alongside chemo to 'boost immunity during treatment,' but concurrent administration actually increases myelosuppression. Pegfilgrastim is once-per-cycle; filgrastim is daily — mixing up the dosing schedule is a frequent test trap.

Clinical Pearl

24-hour rule: never give filgrastim within 24 hours after chemo, and discontinue it at least 24 hours before the next chemo cycle. Bone pain means it's working — marrow is expanding.